Biochemically Recurrent Prostate Cancer

• CLINICAL_TRIALS research · 2026-04-20
  Clinical Trial Update: Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial [Phase 2]

  DIVINE is a Phase 2 trial evaluating stereotactic body radiation therapy with either immediate or delayed androgen receptor pathway inhibito…

• CLINICAL_TRIALS research · 2026-01-20
  Clinical Trial Update: SBRT Versus Hypofractionated Radiotherapy for Biochemically Recurrent or Oligometastatic Prostate Adenocarcinoma [Phase 3]

  A Phase 3 clinical trial compares SBRT versus hypofractionated radiotherapy for biochemically recurrent or oligometastatic prostate cancer; …

• CLINICAL_TRIALS trial_result · 2025-12-02
  Clinical Trial Update: Technology-Enhanced Acceleration of Germline Evaluation for Therapy, TARGET Study [NA]

  This entry reports a completed clinical trial (TARGET) evaluating technology-enhanced germline evaluation for therapy in various stages of p…

• CLINICAL_TRIALS trial_result · 2025-10-15
  Clinical Trial Update: A Study Called ARAMON to Learn to What Extent Does Study Treatment With Darolutamide Affects Testosterone Levels in Men With Prostate Cancer That Had Not Been Treated With Hormonal Therapy Compared to Treatment With Enzalutamide [Phase 2]

  Phase 2 ARAMON study comparing darolutamide with enzalutamide to evaluate the effect on testosterone levels in men with biochemically recurr…

• CLINICAL_TRIALS trial_result · 2021-09-30
  Clinical Trial Update: 68GA-PSMA-11 PET/CT Scan in Impacting Treatment Strategies for Patients With Prostate Cancer [Phase 2]

  Phase 2 trial update evaluating 68Ga-PSMA-11 PET/CT for influencing treatment decisions in biochemically recurrent and metastatic prostate c…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.